Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 3 | BMC Cancer

Figure 3

From: Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer

Figure 3

Expression of hCG in ovarian cancer shown in boxplots. a Expression of hCG in ovarian cancer subtypes shown in boxplots. The boxes represent the range between the 25th and 75th percentiles with a horizontal line at the median. The bars delineate the 5th and 95th percentiles. There were no significant differences in hCG expression between serous, clear cell, endometrioid or mucinous forms of ovarian cancer. b Expression of hCG in all ovarian cancer subtypes shown in boxplots regarding to grading. We identified significant differences in G1, G2 and G3 carcinomas (p = 0.022). The boxes represent the range between the 25th and 75th percentiles with a horizontal line at the median. The bars delineate the 5th and 95th percentiles. The circle indicates values more than 1.5 box lengths. c Expression of hCG in the mucinous ovarian cancer subtype shown in boxplots regarding to staging. We identified significant differences in FIGO I, FIGO II and FIGO III carcinomas (p = 0.018). The boxes represent the range between the 25th and 75th percentiles with a horizontal line at the median. The bars delineate the 5th and 95th percentiles.

Back to article page